Ameliorative effects and mechanisms of an integrated endoplasmic reticulum stress inhibitor on lipopolysaccharide-induced cognitive impairment in mice.
10.11817/j.issn.1672-7347.2025.240262
- Author:
Dandan LIU
1
,
2
;
Wenjia LIU
1
;
Lihua XIE
1
;
Xiaofan XU
3
;
Xiaolin ZHONG
1
;
Wenyu CAO
3
;
Yang XU
4
,
5
;
Ling CHEN
1
,
6
Author Information
1. Department of Endocrinology and Metabolism, First Affiliated Hospital, University of South China, Hengyang
2. 714036750@qq.com.
3. Clinical Anatomy & Reproductive Medicine Application Institute, Hengyang Medical School, University of South China, Hengyang
4. Institute of Neuroscience, Hengyang Medical School, University of South China, Hengyang 421001, China. xuyang2117@
5. com.
6. lingchen-cl@outlook.com.
- Publication Type:Journal Article
- Keywords:
cognitive impairment;
endoplasmic reticulum stress;
hippocampus;
integrated endoplasmic reticulum stress inhibitor;
lipopolysaccharide;
oxidative stress
- MeSH:
Animals;
Lipopolysaccharides;
Male;
Mice, Inbred ICR;
Cognitive Dysfunction/drug therapy*;
Mice;
Oxidative Stress/drug effects*;
Endoplasmic Reticulum Stress/drug effects*;
Hippocampus/drug effects*;
Nitric Oxide Synthase Type II/genetics*;
Guanidines/pharmacology*;
eIF-2 Kinase/antagonists & inhibitors*;
Signal Transduction/drug effects*;
Superoxide Dismutase/metabolism*
- From:
Journal of Central South University(Medical Sciences)
2025;50(6):986-994
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:The integrated endoplasmic reticulum stress inhibitor (ISRIB) is a selective inhibitor of the protein kinase R-like endoplasmic reticulum kinase (PERK) signaling pathway within endoplasmic reticulum stress (ERS) and can improve spatial and working memory in aged mice. Although ERS and oxidative stress are tightly interconnected, it remains unclear whether ISRIB alleviates cognitive impairment by restoring the balance between ERS and oxidative stress. This study aims to investigate the effects and mechanisms of ISRIB on lipopolysaccharide (LPS)-induced cognitive impairment in mice.
METHODS:Eight-week-old male ICR mice were randomly divided into 3 groups: Normal saline (NS) group, LPS group, and ISRIB+LPS group. NS and LPS groups received daily intraperitoneal injections of normal saline for 7 days; on day 7, LPS group mice received intraperitoneal LPS (0.83 mg/kg) to establish a cognitive impairment model. ISRIB+LPS group received ISRIB (0.25 mg/kg) intraperitoneally for 7 days, with LPS injected 30 minutes after ISRIB on day 7. Cognitive ability was evaluated by the novel place recognition test (NPRT). Real-time fluorogenic quantitative PCR (RT-qPCR) was used to detect changes in nitric oxide synthase (NOS), superoxide dismutase-1 (SOD-1), and catalase (CAT) gene expression in the hippocampus and prefrontal cortex. Oxidative stress markers malondialdehyde (MDA), glutathione (GSH), and oxidized glutathione (GSSG), were measured in hippocampal and prefrontal cortex tissues.
RESULTS:Compared with the NS group, mice in LPS group showed a significant reduction in novel place recognition ratio, upregulation of hippocampal NOS-1 and NOS-2 mRNA, downregulation of SOD-1 and CAT mRNA, increased MDA and GSSG, decreased GSH, and reduced GSH/GSSG ratio (all P<0.05). Compared with the LPS group, mice in ISRIB+LPS group exhibited significantly improved novel place recognition, downregulated NOS-1 and NOS-2 mRNA, upregulated SOD-1 and CAT mRNA, decreased MDA and GSSG, increased GSH, and an elevated GSH/GSSG ratio in the hippocampus (all P<0.05). No significant changes were observed in the prefrontal cortex.
CONCLUSIONS:ISRIB improves LPS-induced cognitive impairment in mice by restoring the oxidative/antioxidant balance in the hippocampus.
